Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00959296 · ClinicalTrials.gov registry record

Implantable Systems Performance Registry

A clinical trial of Deep Brain Stimulation and Spinal Cord Stimulation, sponsored by MedtronicNeuro.

Completed
Registry status
10,981
Enrollment target
20
Study locations

NCT00959296 is a study of Deep Brain Stimulation and Spinal Cord Stimulation that has completed, run by MedtronicNeuro. The registered enrollment target is 10,981 participants, above the 85-participant average among 15 other Deep Brain Stimulation trials with a reported enrollment target (12819% higher). The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00959296, a study of Deep Brain Stimulation and Spinal Cord Stimulation, has completed, sponsored by MedtronicNeuro.

COMPLETED
Registry status
10,981 participants
Enrollment target
20
Study locations

Study Summary

The Implantable Systems Performance Registry (ISPR) was developed to evaluate the long-term reliability and performance of market-released Medtronic Neuromodulation infusion and stimulation products. Completion Notice: The ISPR was created by Medtronic to monitor the performance of commercially available products. This registry was initially designed to track performance of Medtronic's implantable infusion and spinal cord stimulation systems beginning in August 2003 and June 2004, respectively. Medtronic DBS Systems were added to the ISPR in June 2009, and Sacral Neuromodulation Systems in April 2010. Medtronic retired the ISPR in April 2016 and merged the data collected from this registry into the Product Surveillance Registry (PSR). Please refer to that record, Clinical Trials identifier: NCT01524276, for further information.

Conditions Studied

Deep Brain Stimulation Spinal Cord Stimulation Drug Infusion (Implantable Pumps) Sacral Neuromodulation

Interventions

  • DEVICE Various

Study Locations (20)

California

  • - Aliso Viejo
  • - Los Angeles
  • - Napa
  • - Palm Springs
  • - Pasadena
  • - San Diego
  • - Upland

Florida

  • Site recruiting for sacral nerve stimulation - Bradenton
  • - Merritt Island
  • - Ocala

Indiana

  • - Evansville
  • - Muncie
  • - South Bend

Georgia

  • - Atlanta
  • - Gainesville

Illinois

  • - Bloomington
  • - Chicago

Alabama

  • - Huntsville

Arizona

  • - Scottsdale

District of Columbia

  • - Washington D.C.

Trial Details

FieldValue
Enrollment Target 10,981 participants
Start Date 2003-08
Est. Completion 2016-09-27

Sponsor

MedtronicNeuro

51 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00959296

The ClinicalTrials.gov registry entry for NCT00959296 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10,981 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 85-participant average among 15 other Deep Brain Stimulation trials with a reported enrollment target (12819% higher). The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Deep Brain Stimulation appearing as the primary indexed condition, and to 1 intervention - of which Various is the first listed.

NCT00959296 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Florida, Indiana.

Frequently Asked Questions

What is clinical trial NCT00959296 about?

NCT00959296 is a clinical study titled "Implantable Systems Performance Registry". The Implantable Systems Performance Registry (ISPR) was developed to evaluate the long-term reliability and performance of market-released Medtronic Neuromodulation infusion and stimulation products. Completion Notice: The ISPR was created by Medtronic to monitor the performance of commercially ava...

What is the current status of trial NCT00959296?

This trial is currently completed. The enrollment target is 10,981 participants. The study started on 2003-08. Estimated completion is 2016-09-27.

What conditions does trial NCT00959296 study?

This clinical trial studies the following conditions: Deep Brain Stimulation, Spinal Cord Stimulation, Drug Infusion (Implantable Pumps), Sacral Neuromodulation.

What interventions are being tested in trial NCT00959296?

The interventions under investigation include: Various (DEVICE).

Who is sponsoring clinical trial NCT00959296?

This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00959296 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Deep Brain Stimulation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Deep Brain Stimulation

All registered trials for this condition

Spinal Cord Stimulation

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.